Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-09 | 2023-01-06 | 177603 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2018-05-23 | 2018-08-18 | 50156 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2021-12-17 | 2022-01-06 | 151347 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2022-12-16 | 2023-01-06 | 178757 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2025-03-27 | 2025-04-04 | 253502 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2024-10-24 | 2024-12-13 | 241084 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154181 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2023-08-12 | 2023-10-27 | 201707 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-07-17 | 2017-08-18 | 15959 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-19 | 2024-05-22 | 216669 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2019-01-30 | 2019-02-01 | 74022 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2023-06-29 | 2024-01-19 | 196946 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2020-10-28 | 2020-11-02 | 127367 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-09-01 | 2022-09-15 | 168418 |
| APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2020-05-13 | 2020-07-06 | 114949 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2023-09-07 | 2023-10-15 | 203825 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-03-13 | 2019-05-06 | 78529 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-09-18 | 2019-11-25 | 94171 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223058 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-06-29 | 2023-08-04 | 196952 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-07-12 | 2019-07-13 | 89135 |
| IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
| IMIPRAMINE | 50MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4593 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |